Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Calcitriol recalled?

Yes — there is an active recall. 2 ongoing FDA recalls mention Calcitriol (9 total). Check the affected lots below.

Most common reason: Labeling / mix-up (2 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Calcitriol. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Calcitriol recalls on record

none so far in 2026; 9 on record, newest first
Class III · Low risk

Rocaltrol (calcitriol)

Subpotency: lower than expected potency result was obtained at the 18 month stability time point.

Terminated Wrong potency / content Validus Pharmaceuticals, Inc. NDC 30698-911-15 D-1171-2018
Class III · Low risk

Calcitriol Oral Solution

Subpotency: lower than expected potency result was obtained at the 18 month stability time point.

Terminated Wrong potency / content Validus Pharmaceuticals, Inc. NDC 63304-241-59 D-1170-2018
Class II · Moderate risk

Calcitriol active pharmaceutical ingredient packaged in varying…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-556-2015
Class II · Moderate risk

Calcitriol Oral Solution 1 mcg/mL

Failed Impurity/Degradation Specification; out of specification for trans-calcitriol degradant at the 9 month stability time point

Terminated Impurity / degradation Boehringer Ingelheim Roxane Inc NDC 0054-3120-41 D-1427-2014
Class II · Moderate risk

Calcitriol

Labeling: Label Mixup: CALCITRIOL, Capsule, 0.25 mcg may be potentially as one of the following drugs: ANAGRELIDE HCL, Capsule, 0.5 mg, NDC 00172524160, Pedigree: AD46414_7, EXP: 5/16/2014; BENAZEPRIL HCL, Tablet, 5 mg, NDC 65162075110, Pedigree: AD52778_7, EXP: 5/20/2014; CINACALCET HCL, Tablet, 30 mg, NDC 55513007330, Pedigree: W003615, EXP: 6/25/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-787-2014
Class II · Moderate risk

CALCITRIOL Capsule

Labeling:Label Mixup; CALCITRIOL, Capsule, 0.5 mcg may be potentially mislabeled as NIACIN TR, Tablet, 250 mg, NDC 10939043533, Pedigree: W003756, EXP: 5/31/2014; ISONIAZID, Tablet, 300 mg, NDC 00555007102, Pedigree: AD32757_28, EXP: 5/13/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-676-2014
Class II · Moderate risk

Vitamin D3 Injection

Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.

Terminated Sterility / contamination FVS Holdings, Inc. dba. Green Valley Drugs D-354-2013